Abstract

Tuberculosis morbidity rates in Poland have been gradually decreasing. Nevertheless, there are approximately 8 thousand cases being registered annually, which includes almost 3 thousand massively infectious patients. In the last 3 years, around 100 cases/year have been reported among children below 14 years of age. Infection with Mycobacterium tuberculosis should be considered in all patients who present symptoms suggesting tuberculosis, have had recent contact with a person suffering from lung tuberculosis or are planned to undergo an immunosuppressive treatment. HIV infected patients are also supposed to have screening tests for M. tuberculosis infection performed. For over a 100 years tuberculin skin test (TST) was the only test capable of confirming tuberculous infection. TST is based on the assessment of skin reaction to intracutaneous injection of tuberculin. Due to cross-reaction to the injected tuberculin in BCG vaccinated individuals, the correct interpretation of the test is difficult. Since 13 years new immunological assays have been available. They are based on detecting interferon gamma (Interferon Gamma Release Assay – IGRA) concentration in blood serum, which has previously been incubated with Mycobacterium tuberculosis antigens absent in the BCG strain. In infected individuals interferon gamma is intensively produced by memory cells in reaction to the contact with previously met Mycobacterium antigens. Many trials have proved IGRA’s high sensitivity and, higher than TST, specificity. Recent guidelines promote the usage of IGRAs, even in children.

References

• 1. American Academy of Pediatrics: Tuberculosis. W: Report ofthe Committee on Infectious Disease. Red Book 2012. 2012, 736-759
  Google Scholar
• 2. American Thoracic Society (ATS) and the Centers for DiseaseControl and Prevention (CDC): Targeted tuberculin testing andtreatment of latent tuberculosis infection. Official statement of theAmerican Thoracic Society. Am. J. Respir. Crit Care Med., 2000; 161:S221-S247
  Google Scholar
• 3. Augustynowicz-Kopeć E., Demkow U., Grzelewska-RzymowskaI., Korzeniewska-Koseła M., Langfort R., Michałowska-Mitczuk D.,Rowińska-Zakrzewska E., Zielonka T.M., Ziołkowski J., Zwolska Z.:Zalecenia Polskiego Towarzystwa Chorób Płuc dotyczące rozpoznawania,leczenia i zapobiegania gruźlicy u dorosłych i dzieci. Pneumonol.Alergol. Pol., 2013; 81: 323-379
  Google Scholar
• 4. Augustynowicz-Kopeć E., Zwolska Z.: Epidemiologia gruźlicyu dzieci i niektóre problemy diagnostyki mikrobiologicznej. Post.Nauk Med., 2008; 9: 569-577
  Google Scholar
• 5. Banfield S., Pascoe E., Thambiran A., Siafarikas A., Burgner D.:Factors associated with the performance of a blood-based interferon-gammarelease assay in diagnosing tuberculosis. PLoS One,2012; 7: e38556
  Google Scholar
• 6. Borkowska D., Zwolska Z., Michałowska-Mitczuk D., Korzeniewska-KosełaM., Zabost A., Napiórkowska A., Kozińska M., BrzezińskaS., Augustynowicz-Kopeć E.: Interferonowy test T-SPOT.TB w diagnostycelatentnego zakażenia prątkiem gruźlicy. Pneumonol. Alergol.Pol., 2011; 79: 264-271
  Google Scholar
• 7. Boussiotis V.A., Tsai E.Y., Yunis E.J., Thim S., Delgado J.C., DascherC.C., Berezovskaya A., Rousset D., Reynes J.M., Goldfeld A.E.: IL-10-producing T cells suppress immune responses in anergic tuberculosispatients. J. Clin. Invest., 2000; 105: 1317-1325
  Google Scholar
• 8. Ceglecka-Tomaszewska K.: Gruźlica u dzieci. PZWL, Warszawa1996
  Google Scholar
• 9. Chiappini E., Accetta G., Bonsignori F., Boddi V., Galli L., BiggeriA., de Martino M.: Interferon-gamma release assays for the diagnosisof Mycobacterium tuberculosis infection in children: a systematicreview and meta-analysis. Int. J. Immunopathol. Pharmacol.,2012; 25: 557-564
  Google Scholar
• 10. Daniel T.M.: The history of tuberculosis. Respir. Med., 2006;100: 1862-1870
  Google Scholar
• 11. Diagnostic Standards and Classification of Tuberculosis in Adultsand Children. This official statement of the American Thoracic Societyand the Centers for Disease Control and Prevention was adoptedby the ATS Board of Directors, July 1999. This statement wasendorsed by the Council of the Infectious Disease Society of America,September 1999. Am. J. Respir. Crit. Care Med., 2000; 161: 1376-1395
  Google Scholar
• 12. Diel R., Loddenkemper R., Nienhaus A.: Evidence-based comparisonof commercial interferon-g release assays for detecting activeTB: a metaanalysis. Chest, 2010; 137: 952-968
  Google Scholar
• 13. Erkens C.G., Kamphorst M., Abubakar I., Bothamley G.H., ChemtobD., Haas W., Migliori G.B., Rieder H.L., Zellweger J.P., Lange C.:Tuberculosis contact investigation in low prevalence countries: a Europeanconsensus. Eur. Respir. J., 2010; 36: 925-949
  Google Scholar
• 14. European Centre for Disease Prevention and Control: Use ofinterferon-gamma release assays in support of TB diagnosis. ECDC;Stockholm 2011
  Google Scholar
• 15. Farhat M., Greenaway C., Pai M., Menzies D.: False-positive tuberculinskin tests: what is the absolute effect of BCG and non-tuberculousmycobacteria? Int. J. Tuberc. Lung Dis., 2006; 10: 1192-1204
  Google Scholar
• 16. Frahm M., Goswami N.D., Owzar K., Hecker E., Mosher A., CadoganE., Nahid P., Ferrari G., Stout J.E.: Discriminating between latentand active tuberculosis with multiple biomarker responses. Tuberculosis,2011; 91: 250-256
  Google Scholar
• 17. Goletti D., Raja A., Syed Ahamed K.B., Rodrigues C., Sodha A.,Carrara S., Vernet G., Longuet C., Ippolito G., Thangaraj S., LeportierM., Girardi E., Lagrange P.H.: Is IP-10 an accurate marker for detectingM. tuberculosis-specific response in HIV-infected persons? PLoSOne, 2010; 5: e12577
  Google Scholar
• 18. Gołąb J., Jakóbisiak M.: Odpowiedzi komórkowe. W: Immunologia,red. J. Gołąb, M. Jakóbisiak, W. Lasek, T. Stokłosa. WydawnictwoNaukowe PWN, Warszawa 2010, 78-93
  Google Scholar
• 19. Huebner R.E., Schein M.F., Bass J.B.Jr.: The tuberculin skin test.Clin. Infect. Dis., 1993; 17: 968-975
  Google Scholar
• 20. Jakubowiak W., Korzeniewska-Kosela M., Kus J.: Podręcznik gruź-licy – Zalecenia Narodowego Programu Zwalczania Gruźlicy, 2001
  Google Scholar
• 21. Kampmann B., Tena-Coki G., Anderson S.: Blood tests for diagnosisof tuberculosis. Lancet, 2006; 368: 282-283
  Google Scholar
• 22. Kellar K.L., Gehrke J., Weis S.E., Mahmutovic-Mayhew A., DavilaB., Zajdowicz M.J., Scarborough R., LoBue P.A., Lardizabal A.A., DaleyC.L., Reves R.R., Bernardo J., Campbell B.H., Whitworth W.C., MazurekG.H.: Multiple cytokines are released when blood from patients withtuberculosis is stimulated with Mycobacterium tuberculosis antigens.PLoS One, 2011; 6: e26545
  Google Scholar
• 23. Korzeniewska-Koseła M.: Gruźlica i Choroby Układu Oddechowegow Polsce w 2014 roku. Instytut Gruźlicy i Chorób Płuc, Warszawa2015
  Google Scholar
• 24. Kucharz E.J.: Historia medycyny. Wkład Krakowa w rozwój światowejmedycyny. Reumatologia, 2012; 50: 276-293
  Google Scholar
• 25. Lalvani A., Connell D.W.: Tuberculosis immunodiagnosis: delvingbelow the surface. Thorax, 2013; 68: 204-206
  Google Scholar
• 26. Lalvani A., Richeldi L., Kunst H.: Interferon gamma assays fortuberculosis. Lancet Infect. Dis., 2005; 5: 322-324
  Google Scholar
• 27. Mack U., Migliori G.B., Sester M., Rieder H.L., Ehlers S., GolettiD., Bossink A., Magdorf K., Hölscher C., Kampmann B., Arend S.M.,Detjen A., Bothamley G., Zellweger J.P., Milburn H. i wsp.: LTBI: latenttuberculosis infection or lasting immune responses to M. tuberculosis?A TBNET consensus statement. Eur. Respir. J., 2009; 33: 956-973
  Google Scholar
• 28. Mandalakas A.M., Detjen A.K., Hesseling A.C., Benedetti A., MenziesD.: Interferon-gamma release assays and childhood tuberculosis:systematic review and meta-analysis. Int. J. Tuberc. Lung Dis.,2011; 15: 1018-1032
  Google Scholar
• 29. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., CastroK., IGRA Expert Committee, Centers for Disease Control and Prevention(CDC): Updated guidelines for using interferon gamma releaseassays to detect Mycobacterium tuberculosis infection – United States, 2010 MMWR Recomm. Rep., 2010; 59 (RR-5): 1-25
  Google Scholar
• 30. Menzies D.: Interpretation of repeated tuberculin tests. Boosting,conversion, and reversion. Am. J. Respir. Crit. Care Med., 1999;159: 15-21
  Google Scholar
• 31. Menzies R., Vissandjee B., Rocher I., St. Germain Y.: The boostereffect in two-step tuberculin testing among young adults in Montreal.Ann. Intern. Med., 1994; 120: 190-198
  Google Scholar
• 32. Pai M., Zwerling A., Menzies D.: Systematic review: T-cell-basedassays for the diagnosis of latent tuberculosis infection: an update.Ann. Intern. Med., 2008; 149: 177-184
  Google Scholar
• 33. QuantiFERON® – TB Gold. (In – Tube Method) Package Insert.www.cellestis.com (30.04.2014)
  Google Scholar
• 34. Rigouts L.: Clinical practice: diagnosis of childhood tuberculosis.Eur. J. Pediatr., 2009; 168: 1285-1290
  Google Scholar
• 35. Schaaf H.S., Zumla A.: Tuberculosis: a comprehensive clinicalreference. Elsevier Health Sciences 2009
  Google Scholar
• 36. Sester M., Sotgiu G., Lange C., Giehl C., Girardi E., Migliori G.B.,Bossink A., Dheda K., Diel R., Dominguez J., Lipman M., Nemeth J.,Ravn P., Winkler S., Huitric E., Sandgren A., Manissero D.: Interferongrelease assays for the diagnosis of active tuberculosis: a systematicreview and meta-analysis. Eur. Respir. J., 2011; 37: 100-111
  Google Scholar
• 37. Sollai S., Galli L., de Martino M., Chiappini E.: Systematic reviewand meta-analysis on the utility of Interferon-gamma release assaysfor the diagnosis of Mycobacterium tuberculosis infection in children:a 2013 update. BMC Infect. Dis., 2014; 14 (Suppl. 1): S6
  Google Scholar
• 38. Solovic I., Sester M., Gomez-Reino J.J., Rieder H.L., Ehlers S., MilburnH.J., Kampmann B., Hellmich B., Groves R., Schreiber S., WallisR.S., Sotgiu G., Schölvinck E.H., Goletti D., Zellweger J.P. i wsp.: Therisk of tuberculosis related to tumour necrosis factor antagonisttherapies: a TBNET consensus statement. Eur. Respir. J., 2010; 36:1185-1206
  Google Scholar
• 39. Starke J.R.: Interferon-gamma release assays for diagnosis of tuberculosisinfection in children. Pediatr. Infect. Dis. J., 2006; 25: 941-942
  Google Scholar
• 40. Strzelak A., Komorowska-Piotrowska A., Ziołkowski J.: CXCL10/IP-10 as a new biomarker for Mycobacterium tuberculosis infection.Pol. Merkur. Lekarski, 2012; 33: 342-345
  Google Scholar
• 41. Sun L., Xiao J., Miao Q., Feng W.X., Wu X.R., Yin Q.Q., Jiao W.W.,Shen C., Liu F., Shen D., Shen A.D.: Interferon gamma release assay indiagnosis of pediatric tuberculosis: a meta-analysis. FEMS Immunol.Med. Microbiol., 2011; 63: 165-173
  Google Scholar
• 42. T-SPOT.TB. (Package Insert). www.tspot.com (30.04.2014)
  Google Scholar
• 43. Thillai M., Pollock K., Pareek M., Lalvani A.: Interferon-gammarelease assays for tuberculosis: current and future applications. ExpertRev. Respir. Med., 2014; 8: 67-78
  Google Scholar
• 44. Thomas T.A., Mondal D., Noor Z., Liu L., Alam M., Haque R., BanuS., Sun H., Peterson K.M.: Malnutrition and helminth infection affectperformance of an interferon g-release assay. Pediatrics, 2010;126: e1522-e1529
  Google Scholar
• 45. Thompson N.J., Glassroth J.L., Snider D.E.Jr., Farer L.S.: The boosterphenomenon in serial tuberculin testing. Am. Rev. Respir. Dis.,1979; 119: 587-597
  Google Scholar
• 46. Whittaker E., Gordon A., Kampmann B.: Is IP-10 a better biomarkerfor active and latent tuberculosis in children than IFNgamma?PLoS One, 2008; 3: e3901
  Google Scholar
• 47. World Health Organization. WHO Global Tuberculosis Report2013
  Google Scholar
• 48. World Health Organization. Guidance for national tuberculosisprogrammes on the management of tuberculosis in children-2nded. WHO: Geneva 2014
  Google Scholar
• 49. Zielonka T.M.: Rola odczynu tuberkulinowego w diagnostycegruźlicy. Med. Dypl., 2006; 15: 20-30
  Google Scholar
• 50. Ziołkowski J.: Gruźlica pierwotna. W: Choroby układu oddechowego.PZWL, Warszawa 2000, 249-269
  Google Scholar
• 51. Zwolska Z.: Praca Roberta Kocha nad rozwojem bakteriologiichorób zakaźnych. Walka z gruźlicą u ludzi i zwierząt w Polsce. Stuleciepierwszego polskiego laboratorium prątka Rudka 1912-2012.Kawdruk: Warszawa 2012
  Google Scholar

Full text